Literature DB >> 2354312

Total bladder replacement in the male and female using the ileocolonic segment (LeBag).

J K Light1, J L Marks.   

Abstract

A group of 11 patients, 2 female and 9 male, underwent total bladder replacement using the ileocolonic segment (LeBag technique) with anastomosis of the bowel to the urethra. The diagnosis was invasive bladder cancer in 10 patients and severe intractable interstitial cystitis in 1. The surgical technique in the male patients was modified to simplify the procedure. The 2 female patients underwent insertion of an artificial sphincter around the bowel segment for a continence mechanism. One patient died 6 weeks post-operatively from a severe coagulopathy. Five of the 9 male patients are continent day and night, relying on their own residual sphincter mechanism, but the remaining 4 required insertion of the artificial urinary sphincter to achieve social continence. The surviving female patient is totally continent. All patients have voiding intervals of 4 to 6 h during the day and are thus continent both day and night, but in some cases the artificial sphincter was necessary to achieve this. Loss of the normal bladder-sphincter reflexes following cystectomy may account for the high incidence of nocturnal incontinence observed in most series. Total bladder replacement is now possible in both male and female patients, thus avoiding an abdominal stoma.

Entities:  

Mesh:

Year:  1990        PMID: 2354312     DOI: 10.1111/j.1464-410x.1990.tb14788.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  2 in total

Review 1.  Bladder replacement in women: a new experience.

Authors:  M Racioppi; A D'Addessi; A Alcini; E Alcini
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1997

2.  The surgical technique and initial outcomes of Anatolian neobladder: a novel technique of ileal neobladder after radical cystectomy.

Authors:  Z Talat; B Onal; B Cetinel; C Demirdag; S Citgez; C Dogan
Journal:  BMC Urol       Date:  2018-10-26       Impact factor: 2.264

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.